Variant Synonymizer: Platform to identify mutations defined in different ways is available now!
Over 2,000 gene–disease validation summaries are now available—no login required!
IMPDH1 (inosine 5'-monophosphate dehydrogenase 1) encodes a ubiquitously expressed enzyme essential for guanine nucleotide biosynthesis that exists as unique, photoreceptor-enriched splice variants in the retina ([PMID:16936083]). Heterozygous missense mutations in IMPDH1 cause autosomal dominant forms of inherited retinal dystrophy (including retinitis pigmentosa type 10 and rare Leber congenital amaurosis) by perturbing non–enzymatic functions despite preserved catalytic activity.
Multiple genetic studies have identified 23 unrelated probands with heterozygous IMPDH1 variants across diverse populations, including single nucleotide changes clustering in exons 8–10 and recurrent alleles c.931G>A (p.Asp311Asn) and c.940A>C (p.Lys314Gln), as well as in-frame and truncating changes absent from controls, segregating with disease in extended families ([PMID:32507954], [PMID:24791140], [PMID:16384941], [PMID:37259572], [PMID:38604988]). The variant spectrum comprises over 56 distinct alleles: 43 missense, 3 in-frame, 1 nonsense, 2 frameshift, 1 synonymous affecting splicing, and 6 intronic variants.
Inheritance is autosomal dominant with evidence of segregation in at least 19 affected relatives from multiple families harboring IMPDH1 mutations. Recurrent founder alleles have not been described, and population carrier frequencies remain low.
Functional work demonstrates that disease-linked mutations (e.g., p.Arg309Pro, p.Asp311Asn, p.Asp226Asn) do not alter catalytic activity but disrupt single-stranded nucleic acid binding, mislocalize between nucleus and cytoplasm, and impair assembly into regulatory filaments (cytoophidia), suggesting a dominant-negative mechanism ([PMID:15882147], [PMID:21791244], [PMID:37731818]). Cryo-EM and biochemical assays reveal that retina-specific terminal extensions modulate filament interfaces and GTP feedback sensitivity, and that pathogenic variants compromise these allosteric controls ([PMID:35013599], [PMID:38323936]). RNAi-mediated suppression of mutant IMPDH1 in murine retina rescues photoreceptor degeneration, underscoring therapeutic potential ([PMID:18385099]).
No robust conflicting evidence disputes the association between heterozygous IMPDH1 mutations and autosomal dominant retinal dystrophy. Additional studies on animal models and long-term natural history exceed current scoring limits.
Key Take-home: Dominant-negative IMPDH1 variants that impair nucleic acid binding and filament regulation lead to progressive inherited retinal dystrophy, providing a rationale for targeted gene-silencing therapies.
Gene–Disease AssociationStrong23 unrelated probands with heterozygous IMPDH1 variants across multiple cohorts, autosomal dominant segregation Genetic EvidenceStrong56 distinct variants (predominantly missense) in 23 probands from ≥10 families, segregating with disease Functional EvidenceStrongIn vitro and in vivo studies demonstrate dominant-negative disruption of nucleic acid binding and filament assembly; rescue by RNAi in murine model |